[GENTING] QoQ TTM Result on 31-Mar-2021 [#1]

Announcement Date
25-May-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Mar-2021 [#1]
Profit Trend
QoQ- -19.47%
YoY- -193.99%
View:
Show?
TTM Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 13,529,534 11,739,980 11,536,663 9,707,909 11,564,060 13,819,008 15,815,173 -9.85%
PBT -970,782 -980,379 -642,033 -1,795,167 -1,526,452 -698,780 195,229 -
Tax -442,305 -324,055 -757,255 -470,264 -547,525 -595,405 -350,529 16.72%
NP -1,413,087 -1,304,434 -1,399,288 -2,265,431 -2,073,977 -1,294,185 -155,300 334.09%
-
NP to SH -1,369,646 -1,214,864 -1,001,057 -1,223,582 -1,024,141 -520,296 -83,868 540.42%
-
Tax Rate - - - - - - 179.55% -
Total Cost 14,942,621 13,044,414 12,935,951 11,973,340 13,638,037 15,113,193 15,970,473 -4.32%
-
Net Worth 31,805,956 32,152,511 32,614,583 33,076,654 32,961,137 33,230,678 34,231,835 -4.76%
Dividend
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Div 423,566 327,301 327,301 577,590 577,590 847,132 847,132 -36.92%
Div Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
Equity
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Net Worth 31,805,956 32,152,511 32,614,583 33,076,654 32,961,137 33,230,678 34,231,835 -4.76%
NOSH 3,876,896 3,876,896 3,876,896 3,876,896 3,876,896 3,876,896 3,876,896 0.00%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -10.44% -11.11% -12.13% -23.34% -17.93% -9.37% -0.98% -
ROE -4.31% -3.78% -3.07% -3.70% -3.11% -1.57% -0.25% -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 351.36 304.89 299.61 252.11 300.32 358.88 410.72 -9.85%
EPS -35.57 -31.55 -26.00 -31.78 -26.60 -13.51 -2.18 540.04%
DPS 11.00 8.50 8.50 15.00 15.00 22.00 22.00 -36.92%
NAPS 8.26 8.35 8.47 8.59 8.56 8.63 8.89 -4.76%
Adjusted Per Share Value based on latest NOSH - 3,876,896
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 348.98 302.82 297.57 250.40 298.28 356.45 407.93 -9.85%
EPS -35.33 -31.34 -25.82 -31.56 -26.42 -13.42 -2.16 541.08%
DPS 10.93 8.44 8.44 14.90 14.90 21.85 21.85 -36.90%
NAPS 8.204 8.2934 8.4126 8.5317 8.5019 8.5715 8.8297 -4.76%
Price Multiplier on Financial Quarter End Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 -
Price 4.67 5.04 4.93 5.03 4.46 3.18 4.10 -
P/RPS 1.33 1.65 1.65 2.00 1.49 0.89 1.00 20.87%
P/EPS -13.13 -15.97 -18.96 -15.83 -16.77 -23.53 -188.24 -82.97%
EY -7.62 -6.26 -5.27 -6.32 -5.96 -4.25 -0.53 488.40%
DY 2.36 1.69 1.72 2.98 3.36 6.92 5.37 -42.10%
P/NAPS 0.57 0.60 0.58 0.59 0.52 0.37 0.46 15.32%
Price Multiplier on Announcement Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 24/02/22 25/11/21 27/08/21 25/05/21 25/02/21 26/11/20 27/08/20 -
Price 4.50 4.94 4.93 4.91 4.63 4.25 3.54 -
P/RPS 1.28 1.62 1.65 1.95 1.54 1.18 0.86 30.26%
P/EPS -12.65 -15.66 -18.96 -15.45 -17.41 -31.45 -162.53 -81.68%
EY -7.90 -6.39 -5.27 -6.47 -5.74 -3.18 -0.62 443.01%
DY 2.44 1.72 1.72 3.05 3.24 5.18 6.21 -46.26%
P/NAPS 0.54 0.59 0.58 0.57 0.54 0.49 0.40 22.08%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment